scholarly journals Rational design of Au nanorods assemblies for highly sensitive and selective SERS detection of prostate specific antigen

RSC Advances ◽  
2015 ◽  
Vol 5 (48) ◽  
pp. 38354-38360 ◽  
Author(s):  
An-qi Yang ◽  
Dong Wang ◽  
Xiang Wang ◽  
Yu Han ◽  
Xue-bin Ke ◽  
...  

A simple SERS immunosensor based on AuNRs assembly was developed for rapid detection of specific antigen in early diagnostics.

2016 ◽  
Vol 85 ◽  
pp. 128-134 ◽  
Author(s):  
Marta Garcia-Cortes ◽  
Jorge Ruiz Encinar ◽  
Jose M. Costa-Fernandez ◽  
Alfredo Sanz-Medel

1995 ◽  
Vol 41 (1) ◽  
pp. 54-58 ◽  
Author(s):  
H Yu ◽  
E P Diamandis

Abstract Prostate-specific antigen (PSA) is believed to be a highly specific marker for normal and cancerous prostatic tissue. We recently found that 30-40% of breast tumors produce PSA. Other data from our group suggest that normal breast can also produce PSA under conditions of stimulation by steroid hormones. In addition, we detected PSA in amniotic fluid. Here we report the presence of PSA in breast milk of lactating women. PSA concentrations in breast milk were quite variable, ranging from < 0.01 microgram/L in 4 of 38 milks to 350 micrograms/L; the median was 0.47 microgram/L. PSA concentration in breast milk was not correlated with mother's age or the sex of the newborn. It did tend to decrease with increasing time postdelivery, but was still detectable 2 weeks postdelivery. PSA in milk was equally measurable by a highly sensitive PSA assay based on time-resolved fluorometry and by the IMx automated PSA method. As confirmed by Western blot analysis, PSA in milk was present predominantly in its 33-kDa form; the PSA-alpha 1-antichymotrypsin complex (100 kDa) was also present but its concentration was < 25% of total PSA. We conclude that the female breast can produce PSA and that PSA is secreted into the milk during lactation; however, the biological role of PSA in milk is unknown. These and other data presented by our group suggest that PSA, a serine protease, may play a role in control of growth in mammary and other tissues through regulation of growth factors, cytokines, and growth-factor-binding proteins.


2020 ◽  
Vol 87 (5) ◽  
pp. 870-876
Author(s):  
I. V. Koktysh ◽  
Ya. I. Melnikova ◽  
O. S. Kulakovich ◽  
A. A. Ramanenka ◽  
S. V. Vaschenko ◽  
...  

1997 ◽  
Vol 4 (3) ◽  
pp. 269-273
Author(s):  
Susumu Akimoto ◽  
Tomohiko Ichikawa ◽  
Koichiro Akakura ◽  
Jun Shimazaki

2014 ◽  
Vol 6 (22) ◽  
pp. 8878-8881 ◽  
Author(s):  
C. K. Tang ◽  
A. Vaze ◽  
J. F. Rusling

Inexpensive, reusable electrochemical chips were configured as immunosensors by using a filter paper disk equipped with antibodies. Rapid detection of cancer biomarker protein prostate specific antigen (PSA) in serum was achieved with 6 pg mL−1 detection in ∼15 min.


2013 ◽  
Vol 11 (38) ◽  
pp. 6493 ◽  
Author(s):  
Katia Nchimi-Nono ◽  
K. David Wegner ◽  
Stina Lindén ◽  
Alexandre Lecointre ◽  
Laurence Ehret-Sabatier ◽  
...  

1996 ◽  
Vol 42 (3) ◽  
pp. 420-423 ◽  
Author(s):  
E W Randell ◽  
E P Diamandis ◽  
G Ellis

Abstract We measured prostate-specific antigen (PSA) in serum from 94 cord- blood samples, from 44 newborns, and from 330 children up to age 18 years, using a highly sensitive "third generation" PSA assay on the IMMULITE (Diagnostic Products Corp.) analyzer. The serum was that remaining after cross-matching for blood transfusion. Most children were hospitalized for special care or surgery. We found detectable concentrations of PSA (> or = 0.003 micrograms/L) in many cord sera and in sera from both male and female neonates. PSA was more frequently detectable in cord and newborn sera from males than from females, but there was considerable overlap in values between the sexes, negating any possible usefulness of PSA for assigning male gender to newborns with ambiguous genitalia. PSA decreased to undetectable concentrations in most prepubertal males and females but became detectable around the age of puberty in males. We speculate that the presence of detectable PSA in cord and newborn sera results from androgenic stimulation of prostatic tissue in males or from stimulation of breast or other tissue by prolactin or progesterone in females.


1996 ◽  
Vol 42 (3) ◽  
pp. 361-366 ◽  
Author(s):  
N Zarghami ◽  
E P Diamandis

Abstract We have developed reverse transcription-polymerase chain reaction (RT- PCR) methods for detecting prostate-specific antigen (PSA) mRNA. Using these methods, and a highly sensitive immunofluorometric assay for measuring PSA protein, we have assessed the concentrations of PSA mRNA and PSA protein in 30 primary breast tumors and a few other control tissues. We found good agreement between presence of PSA protein and PSA mRNA in breast tumors. We thus propose that, in women, detection of PSA protein or PSA mRNA in tissues and tumors offers equivalent information. Because PSA protein is present in male blood and thus could contaminate extracts from tumors and tissues from men, we propose that the RT-PCR methods we describe be used to assess nonprostatic expression of the PSA gene in men.


Sign in / Sign up

Export Citation Format

Share Document